Abstract
The use of orthotopic liver transplantation (OLTX) for the treatment of hepatocellular carcinoma (HCC) has generally become restricted to carefully selected cases of small oligocentric tumors. However, it is not uncommon to find previously undetected HCC within recipient cirrhotic livers at the time of hepatectomy. The impact of unsuspected HCC on patient outcomes remains unclear. A retrospective analysis of our institutional experience with adult primary OLTX was performed comparing recipients with incidental HCC (group l), recipients with known or suspected HCC (group 2), and recipients confirmed by pathologic examination to be tumor free (group 3). Between 1984 and 2000, 27 patients in group 1, 12 patients in group 2, and 612 patients in group 3 underwent primary OLTX. Tumors were smaller (P = 0.0172) in group 1 than in group 2; however, the number of tumors and the histologic findings were similar in the groups. Incidence of bilobar involvement, vascular invasion, portal vein tumor thrombus, lymphatic involvement, and distant metastasis at the time of OLTX did not differ significantly between these groups. Four-year patient survival appeared to be lower in group 1 (70.0%) than in group 3 (79.0%) (P = 0.0546); 4-year patient survival was significantly worse in group 2 (31.0%) compared to group 3 (P = 0.0106). Thus, in our experience, incidentally diagnosed cases of HCC possess many of the same features of malignancy as preoperatively diagnosed HCC. Indeed, patient survival after OLTX appears to be adversely affected by the presence of incidental HCC.
Similar content being viewed by others
References
Starzl TE, Putnam CW, eds. Experience in Hepatic Transplantation. Philadelphia: WB Saunders, 1969.
MacDougal BRD, Williams R. Indications and assessment for orthotopic liver transplantation. In Calne RY, ed. Liver Transplantation. London: Grune & Stratton, 1983, pp 59–66.
Iwatuki S, Gordon RD, Shaw SW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401–407.
O’Grady JG, Poison RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease: Results in 93 consecutive patients. Ann Surg 1988;207:373–379.
Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 consecutive patients with regard to tumor stage and recurrence. Ann Surg 1989;209:88–98.
Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming Kp, Bussutil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg 1990;125:1261–1266.
Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery 1991;110:726–734.
Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, Lewis WD, Cosimi AB. Liver transplantation for primary hepatic cancer. Transplantation 1992;53:376–382.
Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, Van Thiel DH, Carr B, Selby R, Madariaga J. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221–229.
Tan KC, Rela M, Ryder SD, Rizzi PM, Karani J, Portmann B, Heaton ND, Howard ER, Williams R. Experience of orthotopic liver transplantation and hepatic resection for hepatocellular carcinoma of less than 8 cm in patients with cirrhosis. Br J Surg 1995;82:253–256.
Schwartz ME, Sung M, Mor E, Fisher A, Popescu I, Fiel I, Sheiner P, Emre S, Guy S, Miller CM. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995;180:596–603.
Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334:693–699.
Ojogho ON, So SK, Keeffe EB, Berquist W, Conception W, Garcia-Kennedy R, Imperial J, Esquivel CO. Orthotopic liver transplantation for hepatocellular carcinoma: Factors affecting long-term patient survival. Arch Surg 1996;131:935–941.
Philosophe B, Greig PD, Hemming AW, Cattral MS, Wanless I, Rasul I, Baxter N, Taylor BR, Langer B. Surgical management of hepatocellular carcinoma: Resection or transplantation? J GASTROINTEST SURG 1998;2:21–27.
Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: A retrospective analysis. Ann Surg 1998;227:424–432.
Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998;129:643–653.
Ranjan D, Johnston TD. Liver transplantation for hepatocellular carcinoma. Hepatogastroenterology 1998;45:1369–1374.
Van Thiel DH, Colantoni A, DeMaria N. Liver transplantation for hepatocellular carcinoma? Hepatogastroenterology 1998;45:1944–1949.
Chui AK, Rao AR, McCaughan GW, Waugh R, Verran DJ, Koorey D, Sheil AG. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Aust N Z J Surg 1999;69:798–801.
Yamamoto J, Iwatsuki S, Kosuge T, Dvorchik I, Shimada K, Marsh JW, Yamasaki S, Starzl TE. Should hepatomas be treated with hepatic resection or transplantation? Cancer 1999;86:1151–1158.
Neuhaus P, Jonas S, Bechstein WO, Wex C, Kling N, Settmacher U, Al-Abadi H. Liver transplantation for hepatocellular carcinoma. Transplant Proc 1999; 31:469–471.
Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, Fabregat J, Torras J. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: Outcomes based on indicated treatment strategy. J Am Coll Surg 2000;190:580–587.
Strong RW. Transplantation for liver and biliary cancer. Semin Surg Oncol 2000;19:189–199.
Hemming AW, Cattral MS, Reed AI, Van der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652–659.
Tan CK Gores GJ, Steers JL, Porayko MK, Rakela J, Wiesner RH, Krom RA. Ortbotopic liver transplantation for preoperative early-stage hepatocellular carcinoma. Mayo Clin Proc 1994;69:509–514.
Achkar JP, Araya V, Baron RL, Marsh JW, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: Clinical features and outcome after liver transplantation. Liver Transpl Surg 1998; 4:477–482.
Loinaz C, Abradelo M, Gomez R, Colina F, Rey P, Ochando F, Rodriguez Canete A, Gonzalez-Pinto I, Jimenez C, Garcia I, Moreno Gonzalez E. Liver transplantation and incidental primary liver tumors. Transplant Proc 1998;30:3301–3302.
Chui AK, Rao AR, McCaughan GW, Waugh R, Verran DJ, Koorey D, Painter D, Sheil AG. An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: Is it justified? Clin Transplant 1999;13:531–535.
Adham M, Oussoultzoglou E, Ducerf C, Bancel B, Bizollon T, Rode A, Berthoux N, DeLaRoche E, Baulieux J. Results of orthotopic liver transplantation for liver cirrhosis in the presence of incidental and/or undetected hepatocellular carcinoma and tumour characteristics. Transpl Int 1998; 11(Suppl 1):S197-S200.
Khntmalm GB. Liver transplantation for hepatocellular carcinoma: A registry report of the impact of tumor characteristics on outcome. Ann Surg 1998;228:479–490.
Loinaz C, Gomez R, Gonzalez-Pinto I, Jimenez C, Manzan-era M, Ochando F, Rodriguez A, Colina F, Garcia I, Moreno E. A decade of liver transplantation in primary liver tumors. Transplant Proc 1998;30:3296–3297.
Buell JF, Yoshida A, Kim G, Layman R, Hart J, Swanson A, Conjeevarum H, Baker A, Cronin DC, Millis JM. Clinical impact of incidental compared to known hepatomas after orthotopic liver transplantation. Liver Transplant 2000;6:C2.
Molmenti EP, Klintmalm GB. Cancer and liver transplantation. Transplant Rev 2000;14:183–198.
Mion F, Grozel L, Boillot O, Paliard P, Berger F. Adult cirrhotic liver explants: Precancerous lesions and undetected small hepatocellular carcinomas. Gastroenterology 1996;111:1587–1592.
Bismuth H, Adam R, Raccuia J. Liver transplantation for hepatocellular carcinoma in cirrhosis. Trampl Rev 1996;10:13–23.
Akriviadis EA, Llovet JM, Efremidis SC, Shouval D, Canelo R, Ringe B, Meyers WC. Hepatocellular carcinoma. Br J Surg 1998;85:1319–1331.
Schafer DF, Sorrell ME. Hepatocellular carcinoma. Lancet 1999;353:1253–1257.
Rizzi PM, Kane PA, Ryder SD, Ramage JK, Gane E, Tan KC, Portmann B, Karani J, Williams R. Accuracy of radiology in detection of hepatocellular carcinoma before liver transplantation. Gastroenterology 1994;107:1425–1429.
Miller WJ, Baron RL, Dodd GD III, Federle MP. Malignancies in patients with cirrhosis: CT sensitivity and specificity in 200 consecutive transplant patients. Radiology 1994;193:645–650.
Takayasu K, Furukawa H, Wakao F, Muramatsu Y, Abe H, Terauchi T, Winter TC III, Sakamoto M, Hirohashi S. CT diagnosis of early hepatocellular carcinoma: Sensitivity, findings, and CT-pathologic correlation. Am J Roentgenol 1995; 164:885–890.
Shapiro RS, Katz R, Mendelson DS, Halton KP, Schwartz NIE, Miller CM. Detection of hepatocellular carcinoma in cirrhotic patients: Sensitivity of CT and ultrasonography. J Ultrasound Med 1996;15:497–502.
Peterson MS, Baron RL, Marsh JW Jr, Oliver JH III, Confer SR, Hunt LE. Pretransplantation surveillance for possible hepatocellular carcinoma in patients with cirrhosis: Epidemiology and CT-based tumor detection rate in 430 cases with surgical pathologic correlation. Radiology 2000;217:743–749.
Lim JH, Kim CK, Lee WJ, Park CK, Koh KC, Paik SW, Joh JW. Detection of hepatocellular carcinoma and dysplastic nodules in cirrhotic livers: Accuracy of helical CT in transplant patients. Am J Roentgenol 2000;175:693–698.
Makita O, Yamashita Y, Arakawa A, Nakayama Y, Mitsuzaki K, Ando M, Namimoto T, Takahashi M. Diagnostic accuracy of helical CT arterial portography and CT hepatic arteriography for hypervascular hepatocellular carcinoma in chronic liver damage. An ROC analysis. Acta Radio1 2000;41:464–469.
Peterson MS, Baron RL. Radiologic diagnosis of hepatocellular carcinoma. Clin Liver Dis 2001;5:123–144.
Tamura S, Kato T, Berho M, Misiakos EP, O’Brien C, Reddy KR, Nery JR, Burke GW, Schiff ER, Miller J, Tzakis AG. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg 2001;136:25–30.
Zulim RA, Rocco M, Goodnight JE Jr, Smith GJ, Krag DN, Schneider PD. Intraoperative autotransfusion in hepatic resection for malignancy: Is it safe? Arch Surg 1993;128:206–211.
Hansen E, Wolff N, Knuechel R, Ruschoff J, Hofstaedter F, Taeger K. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387–393.
Komeda T, Fukuda Y, Sando T, Kita R, Furukawa M, Nishida N, Amenomori M, Nakao K. Sensitive detection of circulating hepatocellular carcinoma cells in peripheral venous blood. Cancer 1995;75:2214–2219.
Wong IH, Leung T, Ho S, Lau WY, Chan M, Johnson PJ. Semiquantification of circulating hepatocellular carcinoma cells by reverse transcriptase polymerase chain reaction. Br J Cancer 1997;76:628–633.
Wong IH, Lau WY, Leung T, Yeo W, Johnson PJ. Hematogenous dissemination of hepatocytes and tumor cells after surgical resection of hepatocellular carcinoma: A quantitative analysis. Clin Cancer Res 1999;5:4021–4027.
Funaki NO, Tanaka J, Seto SI, Kasamatsu T, Kaido T, Ima-mura M. Hematogenous spreading of hepatocellular carcinoma cells: Possible participation in recurrence in the liver. Hepatology 1997;25:564–568.
Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, Starzl TE. Liver transplantation for hepatocellular carcinoma: A proposal of a prognostic scoring system. J Am Coll Surg 2000;191:389–394.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cho, C.S., Knechtle, S.J., Heisey, D.M. et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 5, 594–602 (2001). https://doi.org/10.1016/S1091-255X(01)80101-3
Issue Date:
DOI: https://doi.org/10.1016/S1091-255X(01)80101-3